Cell Line Derived Xenografts (CDX) Tumor Microarrays (TMAs)

At Crown Bioscience, our CDX Tumor Microarrays (TMAs) are designed to provide researchers with high-quality, homogeneous tumor samples for comprehensive cancer research. These CDX TMAs facilitate high-throughput analysis, essential for biomarker discovery, drug target validation, and translational studies.

Our CDX TMA Catalog Includes:

Why Choose Crown Bioscience’s CDX Tumor Microarrays?

• Uniformity and Quality: Homogeneous tumor samples ensure reliable and reproducible results.
• High-Throughput Analysis: Enables efficient large-scale studies across various cancer types.
• Essential for Research: Crucial for the discovery of novel biomarkers and validation of therapeutic targets.